We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

153 hedge funds and large institutions have $539M invested in NEVRO CORP. in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 53 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 20

9% more funds holding

Funds holding: 140153 (+13)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 53

35% less capital invested

Capital invested by funds: $823M → $539M (-$285M)

91% less call options, than puts

Call options by funds: $1.26M | Put options by funds: $14.2M

Holders
153
Holders Change
+13
Holders Change %
+9.29%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
34
Increased
49
Reduced
53
Closed
20
Calls
$1.26M
Puts
$14.2M
Net Calls
-$13M
Net Calls Change
-$6.32M

NVRO Hedge Fund Activity: Q1 2024 in Review

153 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2024, worth a combined $539M — down 35% from $823M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NVRO positions and 20 closed out — a net gain of 14 holders — while 49 added to existing stakes and 53 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $13.1M. The largest seller was Fidelity Investments, cutting an estimated $17.9M.

  • 153 institutional investors held NEVRO CORP. (NVRO) as of Q1 2024, up from 140 in Q4 2023.
  • Funds reported $539M of NEVRO CORP. stock for Q1 2024, down 35% quarter-over-quarter.
  • 34 funds opened new NEVRO CORP. positions in Q1 2024 and 20 closed out, a net change of +14 holders.
  • The largest NEVRO CORP. buyer in Q1 2024 was Citadel Advisors, an estimated $13.1M added.
  • The largest NEVRO CORP. seller in Q1 2024 was Fidelity Investments, an estimated $17.9M sold.

Based on aggregated 13F filings for Q1 2024.